Edition:
United Kingdom

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

42.98USD
23 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$42.98
Open
$44.16
Day's High
$45.83
Day's Low
$42.28
Volume
152,989
Avg. Vol
200,087
52-wk High
$85.05
52-wk Low
$23.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 5.31 -0.565
Jun '18 40.03 0.300
Mar '18 132.39 3.041
FY 2017 Dec '17 2.04 -0.513
Sep '17 1.34 -0.669
Jun '17 6.56 -0.472
Mar '17 0.46 -0.825
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Quarter Ending Jun-19 2 2.50 5.00 0.00 --
Year Ending Dec-19 7 20.30 32.45 13.70 15.37
Earnings (per share)
Quarter Ending Mar-19 2 -0.87 -0.83 -0.90 --
Quarter Ending Jun-19 2 -0.86 -0.76 -0.95 --
Year Ending Dec-19 5 -3.53 -2.69 -4.78 -3.59
LT Growth Rate (%) 1 2.00 2.00 2.00 -7.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 147.99 49.93
P/E Low - Last 5 Yrs. -- 47.78 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) 117.63 49.51 6.28
Price to Book (MRQ) 4.90 10.16 5.27
Price to Tangible Book (MRQ) 4.91 13.82 6.78
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 74.23 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 176.29 130.05 9.73
Sales (TTM) vs TTM 1 Yr. Ago 5.77 47.86 5.88
Sales - 5 Yr. Growth Rate -- 22.77 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 13.81 75.88 47.26
EPS (TTM) vs TTM 1 Yr. Ago -90.63 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.25
Current Ratio (MRQ) 14.47 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.39
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 79.94 56.29 53.79
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -852.14 -- --
EBITD - 5 Yr. Avg -- -110.25 12.87
Operating Margin (TTM) -872.54 -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.69 8.31
Pre-Tax Margin (TTM) -844.80 -175.21 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.84 8.61
Net Profit Margin (TTM) -839.87 -181.94 3.31
Net Profit Margin - 5 Yr. Avg. -- -137.25 4.89
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 82,598 7,651,345 844,196,423
Net Income/Employee (TTM) -693,720 652,647 100,059,031
Receivable Turnover (TTM) 21.22 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.04 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.49 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -36.22 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.86 15.88
Return on Equity (TTM) -36.40 10.14 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -39.52 -8.99 --
EPS (TTM) % -146.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Regenxbio Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 30.93 26.42 99 99
13 Week 66.17 58.08 99 95
26 Week 98.53 83.43 99 98
52 Week 119.08 85.68 99 72
YTD 81.40 59.31 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.78%
# of Holders: 286
Total Shares Held: 29,308,562
3 Mo. Net Change: 55,982
# New Positions: 2
# Closed Positions: 5
# Increased Positions: 13
# Reduced Positions: 22
# Net Buyers: -9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.